This study showed that CD3-BsAbs with a high affinity CD3 arm accumulated in T-cell-rich tissues, such as the spleen and lymph nodes, whereas CD3-low affinity BsAbs accumulated mainly in the HER2+ tumor, thereby affecting the biodistribution and treatment outcome [119]. This evidence concerns the gene ERBB2 and neoplasm.